A high proportion of people over the age of 40 in the United States is at risk of developing diabetes mellitus, type 2. The American Diabetes Association expects that this population is [increasing in the future]. Diabetes mellitus, type 2 will then become the leading cause of diabetes morbidity and mortality in the United States.
Diabetes mellitus type 2 can be a debilitating condition that often leads to insulin resistance and results in high blood sugar. Diabetes mellitus type 2 can cause serious health complications.
Treatment for patients affected by diabetes can be tailored to treat complications. Drug treatment is typically directed toward lowering blood sugar, while nonspecific diabetes management is targeted at managing comorbidities associated with diabetes. Medications for comorbid conditions, such as diabetes, are often indicated based on the presence of diabetes-associated comorbidities. Obesity, a more serious but treatable condition, is typically managed by caloric restriction and/or weight loss.
Diabetes, type 2 can be cured by good lifestyle choices. Many patients diagnosed with diabetes, type 2 will have significant health problems long after diagnosis due to poor glycemic control or poor disease management; however, many of these can be prevented by diet changes and exercise improvements.
The exact cause of diabetes mellitus type 2 remains unclear, but factors that have been suggested include: a defective metabolism of body fat (abnormalities in the action of insulin), the development of pancreatic autoimmunity, or abnormal endocrine and metabolic functions. There are several theories regarding how diabetes mellitus type 2 causes chronic low insulin production. However, as little is actually known about this disease due to its rarity, progress in the diagnosis, and treatment of the condition are difficult. It is most likely that both inherited and acquired factors play some roles in the development of type 2 diabetes mellitus. The diagnosis usually comes after several years of high blood sugar and frequent checking with diabetic tests.
Signs of diabetes mellitus, type 2 include a decreased ability to see or think clearly, a loss of feeling in the feet, frequent urination and excessive thirst. As the two conditions develop, complications may be seen. Early signs of diabetes mellitus, type 2 may include weight loss, blurred vision, frequent urination, dry skin, frequent infections and low-grade fever.\n
Current medical therapy for diabetes mellitus, type 2, appears optimal. However, many patients are not receiving the existing treatment, and a large proportion of patients have suboptimal glycemic control. Thus, more patients with type 2 diabetes could benefit from medical treatment.
Results from a recent clinical trial of our current randomized clinical trial showed for both postoperative nausea and vomiting that oral aspirin 80 mg ec tab was not significantly different from placebo. Results from a recent clinical trial has implications for the use of aspirin as a postoperative analgesic.
Ec tab aspirin 80 mg tablets are comparable to the capsule form of aspirin in terms of bioavailability and safety. In the treatment of hypercholesterolaemia, there appears to be little or no difference in the efficacy and safety of the capsule form and ec tab aspirin 80 mg tablets. The ec tab is therefore preferred to the capsule form for these indications.
It appears that the major side effects are gastrointestinal, whereas a few more minor ones are also present, but occur less often. The side effects recorded in our study (for example, dyspepsia, gastritis, colitis) are not necessarily due to aspirin and are not listed in the drug information sheets. However, as our study cannot refute a possible causality, one should read the information sheets thoroughly before taking aspirin. In case of gastrointestinal side effects after initiation of treatment with ASA, or of GI problems after treatment is discontinued, in particular during the first week of treatment, a re-evaluation of the effectiveness and mode of action of the specific treatment is required.
In terms of life expectancy, DM2 may be a [little less] serious condition than other conditions with significant morbidity and mortality, such as myocardial infarction and cancer. However, DM2 does confer a higher risk of mortality in the first 10 years following diagnosis. Additionally, with careful medical management, DM2 can improve long-term outcome, which makes its treatment less urgent.